Study Looks at Alcohol Intake, Mortality Link in Steatotic Liver Disease

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

THURSDAY, Dec. 14, 2023 -- For individuals with steatotic liver disease (SLD) at low risk for advanced fibrosis, there is a nonlinear association between alcohol consumption and mortality, with increased risk at or above consumption of 7.4 g/day, according to a research letter published online Dec. 14 in JAMA Network Open.

Yee Hui Yeo, M.D., from Cedars-Sinai Medical Center in Los Angeles, and colleagues examined the dose-dependent association of alcohol use with progression of SLD using a noninvasive method based on data from the U.S. National Health and Nutrition Examination Survey III (1988 to 1994) database, followed through Dec. 31, 2019.

The researchers found that 20.8 percent of the 2,834 individuals with SLD had intermediate or high risk of advanced fibrosis, with male predominance and higher prevalence of metabolic disorders. Individuals at intermediate or high risk of advanced fibrosis had a mortality rate of 4,342 per 100,000 persons during 66,299 person years of follow-up, compared with 1,099 per 100,000 persons in the low-risk group. A nonlinear association between alcohol consumption and mortality was seen in the low-risk group after adjustment for demographic characteristics and metabolic variables. At a 7.4-g daily intake, mortality risk exceeded an adjusted hazard ratio of 1.00. In the intermediate- or high-risk groups, a linear association was observed between daily alcohol consumption and increased mortality risk.

"The finding aligns with previous research indicating higher risk of fibrosis progression among moderate drinkers," the authors write. "Individuals with SLD should be advised to maintain regular health monitoring and lifestyle management."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords